<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
<channel>
	<generator>Vivvo CMS 4.1</generator>
	<title>PRI: Public Radio International</title>
	<link>http://www.pri.org/</link>
	<copyright>&amp;copy;2010 Spoonlabs d.o.o.</copyright>
	<image>
		<title>PRI: Public Radio International</title>
		<url>http://www.pri.org/files.php?file=rss_682409203.gif</url>
		<link>http://www.pri.org/</link>
	</image>
	
			
				
					<item>
						
							<title>FDA panel recommends approval of prophylactic use of HIV prevention drug</title>
							<link>http://www.pri.org/stories/health/tt-fda-panel-recommends-approval-of-prophylactic-use-of-hiv-prevention-drug-9849.html</link>
							<category>Health and Medicine</category>
							<pubDate>Fri, 11 May 2012 13:54:00 -0500</pubDate>
							<description>Truvada, long used to treat people already infected with HIV, may soon be available as another means of preventing initial HIV infection. That was the recommendation of an FDA advisory panel that has been looking into the idea.</description>
							
						
					</item>
					
							
						
				
			
		




<description>PRI: Public Radio International</description>
</channel>
</rss>